SEER 1975–2023 analysis demonstrated a long-term mortality inflection from rising rates to sustained declines, with the ...

Physical Activity Improves Performance, Frailty Scores, PROs in Multiple Myeloma Bispecific antibodies may be more broadly applicable as treatment for patients with multiple myeloma in the short-term, ...

Oncology nurse practitioners discuss CD38-based frontline therapy for newly diagnosed multiple myeloma, including Dara-VRd ...

Why it matters: Multiple myeloma is the second most common blood cancer in adults, affecting over 127,000 Americans, with survival rates steadily improving due to treatment advances. What’s changing: ...

Each monthly installment examines an aspect of multiple myeloma care, including delivering the diagnosis, building trust, ...

Early stage multiple myeloma is often asymptomatic, and early symptoms can be subtle and easy to miss. Delayed diagnosis and treatment may affect survival. Possible early symptoms include bone pain, ...

Anemia often goes hand-in-hand with multiple myeloma. Sometimes, the cancer causes the anemia. And sometimes, the cancer treatment does. But it's possible to resolve it and feel better. (Photo Credit: ...

When it comes to matching the commercial scale-up to the innovations taking place across Kite’s pipeline, Alquist admitted ...

Although patients with the same cancer diagnosis may respond very differently to treatment, clinicians still have limited ...

Intensive Therapy More Effective vs Less Intense Therapy in Frail Patients With MM BCMA and GPRC5D loss in patients with multiple myeloma may lead to resistance to continuous treatment with anti–BCMA ...

Multiple myeloma starts with genetic changes in plasma cells, which are not inherited but occur spontaneously. The condition progresses from monoclonal gammopathy of undetermined significance (MGUS) ...